On November 12, 2024, the Global Coalition on Aging and the Acton Institute brought together a diverse group of thought leaders—including senior clergy, scientists, G7 leaders, patient advocates, and private sector innovators—at the Pontifical Academy of Sciences in Vatican City for a critical discussion on antimicrobial resistance (AMR). The event, entitled Solving for Antimicrobial Resistance:…

Following the passage of the Inflation Reduction Act in 2022, healthcare systems in the United States are facing many changes in the name of saving costs and creating efficiencies. But do the benefits actually outweigh the costs?  GCOA’s issue brief, “Utilization Management Post-Inflation Reduction Act and the Threat to Healthy Aging,” addresses the unintended negative consequences…

This new GCOA paper, launched ahead of Silver Economy Forum 2024, examines how industry leaders are creating business value, engaging their workforce, improving productivity and economic value, and advancing top private-sector priorities by taking action on preventive health for their employees through employee benefits and policies, such as supporting access to adult immunization, mental health…

Despite tremendous scientific innovation and the availability of advanced treatments, ageist systems, attitudes, and beliefs continue to place countless lives at unnecessary risk by preventing timely access to care and treatment. The paper shares evidence of ageism’s impact on health outcomes and system costs and outlines concrete steps for stakeholders to take in the fight…

On June 6, 2024, The Global Coalition on Aging (GCOA) Alliance for Health Innovation convened a roundtable discussion of cross-sectoral experts representing patients, caregivers, academia, biopharmaceutical innovators, and business communities to discuss Prescription Drug Affordability Boards (PDABs), Upper Payment Limits (UPLs), and the risk they pose to the innovation that is needed to safeguard healthy…